NEW YORK – Personal Genome Diagnostics said today that it has successfully CE marked its PGDx Elio tissue complete assay, allowing the company to provide greater access to precision medicine for cancer patients in the European Union.
NEW YORK – Personal Genome Diagnostics said today that it has successfully CE marked its PGDx Elio tissue complete assay, allowing the company to provide greater access to precision medicine for cancer patients in the European Union.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.